The 5-year longitudinal diagnostic profile and health services utilization of patients treated with electroconvulsive therapy in Quebec: a population-based study.
Comorbidities
Depression
Epidemiology
HiTOP
Observational studies
Schizophrenia
Journal
Social psychiatry and psychiatric epidemiology
ISSN: 1433-9285
Titre abrégé: Soc Psychiatry Psychiatr Epidemiol
Pays: Germany
ID NLM: 8804358
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
received:
17
07
2022
accepted:
15
09
2022
medline:
4
4
2023
pubmed:
28
9
2022
entrez:
27
9
2022
Statut:
ppublish
Résumé
Electroconvulsive therapy (ECT) is effective for treating several psychiatric disorders. However, only a minority of patients are treated with ECT. It is of primary importance to characterize their profile for epidemiological purposes and to inform clinical practice. We aimed to characterize the longitudinal profile of psychopathology and services utilization of patients first treated with ECT. We conducted a population-based comparative study using data from a national administrative database in Quebec. Patients who received a first ECT between 2002 and 2016 were compared to controls who were hospitalized in psychiatry but did not receive ECT. We performed descriptive analyses to compare psychiatric diagnoses, domains of psychopathology (internalizing, externalizing and thought/psychotic disorders), medical services and medication use in the 5 years prior to the ECT or hospitalization. 5 080 ECT patients were compared with 179 594 controls. Depressive, anxiety, bipolar and psychotic disorders were more frequent in the ECT group. 96.2% of ECT patients had been diagnosed with depression and 53.8% with a primary psychotic disorder. In the ECT group, 1.0% had been diagnosed exclusively with depression and 47.0% had disorders from that belong to all three domains of psychopathology. Having both internalizing and thought/psychotic disorders was associated with an increased likelihood of receiving ECT vs having internalizing disorders alone (unadjusted OR = 2.93; 95% CI = 2.63, 3.26). All indicators of mental health services utilization showed higher use among ECT patients. Our results provide robust evidence of complex longitudinal psychopathology and extensive services utilization among ECT patients.
Identifiants
pubmed: 36163429
doi: 10.1007/s00127-022-02369-w
pii: 10.1007/s00127-022-02369-w
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
629-639Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
Références
Blais C, Jean S, Sirois C, Rochette L, Plante C, Larocque I, Doucet M, Ruel G, Simard M, Gamache P (2014) Quebec integrated chronic disease surveillance system (QICDSS), an innovative approach. Chronic Dis Inj Can 34(4):226–235
doi: 10.24095/hpcdp.34.4.06
pubmed: 25408182
Abrams R (2002) Electroconvulsive therapy. Oxford University Press
Ionescu DF, Rosenbaum JF, Alpert JE (2015) Pharmacological approaches to the challenge of treatment-resistant depression. Dialogues Clin Neurosci 17(2):111. https://doi.org/10.31887/DCNS.2015.17.2/dionescu
doi: 10.31887/DCNS.2015.17.2/dionescu
pubmed: 26246787
pmcid: 4518696
Weiss A, Hussain S, Ng B, Sarma S, Tiller J, Waite S, Loo C (2019) Royal Australian and New Zealand College of Psychiatrists professional practice guidelines for the administration of electroconvulsive therapy. Aust N Z J Psychiatry 53(7):609–623. https://doi.org/10.1177/0004867419839139
doi: 10.1177/0004867419839139
pubmed: 30966782
Leiknes KA, Schweder LJV, Høie B (2012) Contemporary use and practice of electroconvulsive therapy worldwide. Brain Behavior 2(3):283–344. https://doi.org/10.1002/brb3.37
doi: 10.1002/brb3.37
pubmed: 22741102
pmcid: 3381633
Kennedy SH, Lam RW, McIntyre RS, Tourjman SV, Bhat V, Blier P, Hasnain M, Jollant F, Levitt AJ, MacQueen GM (2016) Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. Pharmacological treatments. Can J Psychiatry 61(9):540–560. https://doi.org/10.1177/0706743716659417
doi: 10.1177/0706743716659417
pubmed: 27486148
pmcid: 4994790
Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD (2006) Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR* D report. Am J Psychiatry 163(11):1905–1917. https://doi.org/10.1176/ajp.2006.163.11.1905
doi: 10.1176/ajp.2006.163.11.1905
pubmed: 17074942
Lam RW, McIntosh D, Wang J, Enns MW, Kolivakis T, Michalak EE, Sareen J, Song W-Y, Kennedy SH, MacQueen GM (2016) Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 1. Disease burden and principles of care. Can J Psychiatry 61(9):510–523. https://doi.org/10.1177/0706743716659416
doi: 10.1177/0706743716659416
pubmed: 27486151
pmcid: 4994789
Lemasson M, Haesebaert J, Rochette L, Pelletier E, Lesage A, Patry S (2018) Electroconvulsive therapy practice in the Province of Quebec: linked health administrative data study from 1996 to 2013. Can J Psychiatry 63(7):465–473. https://doi.org/10.1177/0706743717738492
doi: 10.1177/0706743717738492
pubmed: 29069982
Grote NK, Frank E (2003) Difficult-to-treat depression: the role of contexts and comorbidities. Biol Psychiat 53(8):660–670. https://doi.org/10.1016/s0006-3223(03)00006-4
doi: 10.1016/s0006-3223(03)00006-4
pubmed: 12706952
Cailhol L, Pelletier É, Rochette L, Renaud S, Koch M, David P, Villeneuve E, Lunghi C, Lesage A (2021) Utilization of health care services by patients with cluster B personality disorders or Schizophrenia. Psychiatr Serv 72(12):1392–1399. https://doi.org/10.1176/appi.ps.202000554
doi: 10.1176/appi.ps.202000554
pubmed: 34281361
Huỳnh C, Kisely S, Rochette L, Pelletier É, Jutras-Aswad D, Larocque A, Fleury MJ, Lesage A (2021) Using administrative health data to estimate prevalence and mortality rates of alcohol and other substance-related disorders for surveillance purposes. Drug Alcohol Rev 40(4):662–672. https://doi.org/10.1111/dar.13235
doi: 10.1111/dar.13235
pubmed: 33432695
Kotov R, Krueger RF, Watson D, Achenbach TM, Althoff RR, Bagby RM, Brown TA, Carpenter WT, Caspi A, Clark LA (2017) The hierarchical taxonomy of psychopathology (HiTOP): a dimensional alternative to traditional nosologies. J Abnorm Psychol 126(4):454. https://doi.org/10.1037/abn0000258
doi: 10.1037/abn0000258
pubmed: 28333488
DeYoung CG, Kotov R, Krueger RF, Cicero DC, Conway CC, Eaton NR, Forbes MK, Hallquist MN, Jonas KG, Latzman RD (2022) Answering questions about the Hierarchical Taxonomy of Psychopathology (HiTOP): analogies to whales and sharks miss the boat. Clin Psychol Sci 10(2):279–284. https://doi.org/10.1177/21677026211049390
doi: 10.1177/21677026211049390
pubmed: 35444863
Lemasson M, Patry S, Massamba V, Rochette L, Pelletier É, Lesage A (2021) Profil d’utilisation de l’électroconvulsivothérapie chez l’adulte au Québec: mise à jour 2020.
Kotov R, Krueger RF, Watson D, Cicero DC, Conway CC, DeYoung CG, Eaton NR, Forbes MK, Hallquist MN, Latzman RD (2021) The hierarchical taxonomy of psychopathology (HiTOP): a quantitative nosology based on consensus of evidence. Annu Rev Clin Psychol 17:83–108. https://doi.org/10.1146/annurev-clinpsy-081219-093304
doi: 10.1146/annurev-clinpsy-081219-093304
pubmed: 33577350
Krueger RF, Hobbs KA, Conway CC, Dick DM, Dretsch MN, Eaton NR, Forbes MK, Forbush KT, Keyes KM, Latzman RD (2021) Validity and utility of hierarchical taxonomy of Psychopathology (HiTOP): II externalizing superspectrum. World Psychiatry 20(2):171–193. https://doi.org/10.1002/wps.20844
doi: 10.1002/wps.20844
pubmed: 34002506
pmcid: 8129870
Pampalon R, Hamel D, Gamache P, Philibert MD, Raymond G, Simpson A (2012) An area-based material and social deprivation index for public health in Québec and Canada. Can J Public Health/Revue Canadienne de Sante’e Publique. https://doi.org/10.1007/BF03403824
doi: 10.1007/BF03403824
Austin PC (2009) Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med 28(25):3083–3107. https://doi.org/10.1002/sim.3697
doi: 10.1002/sim.3697
pubmed: 19757444
pmcid: 3472075
Kaster TS, Blumberger DM, Gomes T, Sutradhar R, Dasklakis ZJ, Wijeysundera DN, Vigod SN (2020) Patient-level characteristics and inequitable access to inpatient electroconvulsive therapy for depression: a population-based cross-sectional study: caractéristiques au niveau du patient et accès inéquitable à la thérapie électroconvulsive pour patients hospitalisés. Can J Psychiatry. https://doi.org/10.1177/0706743720935647
doi: 10.1177/0706743720935647
pubmed: 32613857
pmcid: 7918876
Caspi A, Moffitt TE (2018) All for one and one for all: mental disorders in one dimension. Am J Psychiatry 175(9):831–844. https://doi.org/10.1176/appi.ajp.2018.17121383
doi: 10.1176/appi.ajp.2018.17121383
pubmed: 29621902
pmcid: 6120790
Kellner C, Obbels J, Sienaert P (2019) When to consider electroconvulsive therapy (ECT). Acta Psychiatr Scand. https://doi.org/10.1111/acps.13134
doi: 10.1111/acps.13134
pubmed: 31774547
pmcid: 6881820
Verona E, Sachs-Ericsson N, Joiner TE Jr (2004) Suicide attempts associated with externalizing psychopathology in an epidemiological sample. Am J Psychiatry 161(3):444–451. https://doi.org/10.1176/appi.ajp.161.3.444
doi: 10.1176/appi.ajp.161.3.444
pubmed: 14992969
Nordenskjöld A, von Knorring L, Engström I (2012) Predictors of the short-term responder rate of Electroconvulsive therapy in depressive disorders-a population based study. BMC Psychiatry 12(1):1–7. https://doi.org/10.1186/1471-244X-12-115
doi: 10.1186/1471-244X-12-115
Yip AG, Ressler KJ, Rodriguez-Villa F, Siddiqi SH, Seiner SJ (2021) Treatment outcomes of electroconvulsive therapy for depressed patients with and without borderline personality disorder: a retrospective cohort study. J Clin Psychiatry. https://doi.org/10.4088/JCP.19m13202
doi: 10.4088/JCP.19m13202
pubmed: 33471448
Rönnqvist I, Nilsson FK, Nordenskjöld A (2021) Electroconvulsive therapy and the risk of suicide in hospitalized patients with major depressive disorder. JAMA Netw Open 4(7):e2116589–e2116589. https://doi.org/10.1001/jamanetworkopen.2021.16589
doi: 10.1001/jamanetworkopen.2021.16589
pubmed: 34287633
pmcid: 8295734